Oct 4 (Reuters) - Dancann Pharma A/S DANCAN.TE :
* ACQUIRES CANNGROS APS AND BECOMES MARKET LEADER IN THE
DANISH
MARKET UNDER THE PILOT PROGRAMME WITH MEDICAL CANNABIS
* UNDER TERMS, OWNERS OF CANNGROS WILL RECEIVE 7 MDKK OF
DANCANN
PHARMA SHARES AT A MARKET PRICE ISSUED AT DKK 3.664 PER SHARE
* 100% OF CONSIDERATION SHARES WILL BE SUBJECT TO A 1-YEAR
LOCK-UP PERIOD FROM DATE OF COMPLETION OF TRANSACTION
* CLOSING OF TRANSACTION ARE SUBJECT TO CUSTOMARY CONDITIONS
AND
CLOSING IS EXPECTED TO TAKE PLACE DURING OCTOBER 2021
* TRANSACTION ALSO INCLUDES A 6 MDKK PAYABLE IN CASH OVER
TWO
INSTALLMENTS
Source text for Eikon: ID:nWkr3fhwfW
Further company coverage: DANCAN.TE
((Reuters.Briefs@thomsonreuters.com;))